C-terminal pro-ghrelin peptides are present in the human circulation

Biochemical and Biophysical Research Communications

Volumn 310, Issue 2, 2003, Pages 567-573

  Pemberton, Chris ^a   Wimalasena, Prasangi ^a   Yandle, Tim ^a   Soule, Steven ^a   Richards, Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Ghrelin; Molecular form; Pro ghrelin; Protein processing

Indexed keywords

GHRELIN; PEPTIDE DERIVATIVE;

ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CIRCULATION; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0141458929     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.045     Document Type: Article

References (28)

1. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660.
2. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., Bloom S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 141:2000;4325-4328.
3. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes. 50:2001;707-709.
4. Rigamonti A.E., Pincelli A.I., Corra B., Viarengo R., Bonomo S.M., Galimberti D., Scacchi M., Scarpini E., Cavagnini F., Muller E.E. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J. Endocrinol. 175:2002;R1-R5.
5. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., Hosoda H., Shimizu W., Yamagishi M., Oya H., Koh H., Yutani C., Kangawa K. Elevated circulating level of ghrelin in cachexia associated with heart failure. Circulation. 104:2001;2034-2038.
6. 125I-His(9)]-ghrelin, a novel radioligand for localising GHS orphan receptors in human and rat tissue: upregulation of receptors with atherosclerosis. Br. J. Pharmacol. 134:2001;143-149.
7. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolino F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159:2002;1029-1037.
8. Hosoda H., Kojima M., Mizushima T., Shimizu S., Kangawa K. Structural divergence of human ghrelin: identification of multiple ghrelin derived molecules produced by post-translational processing. J. Biol. Chem. 278:2003;64-70.
9. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., Nakao K. Stomach is a major source of circulating ghrelin and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 86:2001;4753-4758.
10. Hunt P.J., Yandle T.G., Nicholls M.G., Richards A.M., Espiner E.A. The amino terminal portion of pro-Brain natriuretic peptide circulates in human plasma. Biochem. Biophys. Res. Commun. 214:1995;1175-1183.
11. Yandle T.G., Espiner E.A., Nicholls M.G., Duff H. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J. Clin. Endocrinol. Metab. 63:1986;72-79.
12. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature. 407:2000;908-913.
13. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., Hayashi Y., Kangawa K. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. 280:2001;R1483-R1487.
14. 2+ channels and PKC, in: Proceedings of the 45th Annual Scientific Meeting of the Endocrine Society of Australia, 2002, p. NZ36.
15. Nagaya N., Miyatake K., Uematsu M., Oya H., Shimizu W., Hosoda H., Kojima M., Nakanishi N., Mori H., Kangawa K. Hemodynamic, renal and hormonal effects of ghrelin infusion in patients with chronic heart failure. J. Clin. Endocrinol. Metab. 86:2001;5854-5859.
16. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., Hosoda H., Hirota Y., Ishida H., Mori H., Kangawa K. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. 104:2001;1430-1435.
17. Hosoda H., Kojima M., Matsuo H., Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 279:2000;909-913.
18. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S. A role for ghrelin in the central regulation of feeding. Nature. 409:2001;194-198.
19. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., Guan J.L., Wang Q.P., Funahashi H., Sakurai T., Shioda S., Matsukura S., Kangawa K., Nakazato M. Ghrelin-induced food intake is mediated via the Orexin pathway. Endocrinology. 144:2003;1506-1512.
20. Norrelund H., Hansen T.K., Orskov H., Hosoda H., Kojima M., Kangawa K., Weeke J., Moller N., Christiansen J.S., Jorgensen J.O. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin. Endocrinol. 57:2002;539-546.
21. Shimada M., Date Y., Mondal M.S., Toshinai K., Shimbara T., Fukunaga K., Murakami N., Miyazato M., Kangawa K., Yoshimatsu H., Matsuo H., Nakazato M. Somatostatin suppresses ghrelin secretion from the rat stomach. Biochem. Biophys. Res. Commun. 302:2003;520-525.
22. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., Nozoe S., Hosoda H., Kangawa K., Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 87:2002;240-244.
23. Schollberg K., Jaross W., Seiler E., Haschke A., Wilke W., Schmidt G., Hentschel R., Assmus B., Schirmer G. Pituitary and adrenal hormones in patients after myocardial infarction under ergometer load. Atherosclerosis. 49:1983;163-170.
24. Conti E., Andreotti F., Sciahbasi A., Riccardi P., Marra G., Menini E., Ghirlanda G., Maseri A. Markedly reduced insulin like growth factor-1 in the acute phase of myocardial infarction. J. Am. Coll. Cardiol. 38:2001;26-32.
25. Stubbs P.J., Laycock J., Alaghband-Zadeh J., Carter G., Noble M.I. Circulating stress hormone and insulin concentrations in acute coronary syndromes: identification of insulin resistance on admission. Clin. Sci. 96:1996;589-595.
26. Richards A.M., Nicholls M.G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G., Buttimore R.C., Lainchbury J.G., Elliott J.M., Ikram H., Crozier I.G., Smyth D.W. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohumoral predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929.
27. Richards A.M., Nicholls M.G., Troughton R.W., Lainchbury J.G., Elliott J., Frampton C., Espiner E.A., Crozier I.G., Yandle T.G., Turner J. Antecedent hypertension and heart failure after myocardial infarction. J. Am. Coll. Cardiol. 39:2002;1182-1188.
28. Yoshimoto A., Mori K., Sugawara A., Mukoyama M., Yahata K., Suganami T., Takaya K., Hosoda H., Kojima M., Kangawa K., Nakao K. Plasma ghrelin and des-acyl ghrelin concentrations in renal failure. J. Am. Soc. Nephrol. 13:2002;2748-2752.